Xustreas 3-7 1d【XUT7】銘柄情報 | ADVFN

US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
ETF
イギリス
LSE
Xustreas 3-7 1d (XUT7) 銘柄情報

Xustreas 3-7 1d (XUT7)

32.73

0.00

( 0.00% )

更新日時： 00:51:19

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

32.73

買値

32.86

売値

32.875

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

32.73

始値

-

時刻

最終取引時間

-

財務取引量

-

VWAP

-

平均取引量 (3 か月)

-

発行済株式数

1,992,048,000

配当利回り

-

PER

0.00

1 株当たり利益 (EPS)

-

歳入

28.92B

純利益

4.77B

セクター

Commercial Banks, Nec

業界

Commercial Banks, Nec

ウェブサイト

www.deutsche-bank.com

本社

Frankfurt Am Main, Deu

設立

-

Xustreas 3-7 1d is listed in the Commercial Banks sector of the ロンドン証券取引所 with ticker XUT7. The last closing price for Xustreas 3-7 1d was US$32.73. Over the last year, Xustreas 3-7 1d shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Xustreas 3-7 1d currently has 1,992,048,000 shares in issue. The market capitalisation of Xustreas 3-7 1d is US$65.20 billion.

No news to show yet.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	SP
4	0	0	0	0	0	0	0	SP
12	0	0	0	0	0	0	0	SP
26	0	0	0	0	0	0	0	SP
52	0	0	0	0	0	0	0	SP
156	0	0	0	0	0	0	0	SP
260	0	0	0	0	0	0	0	SP

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
QMCOQuantum Corporation	US$ 21.59 (136.47%)	16.44M
RGTIRigetti Computing Inc	US$ 3.045 (75.00%)	179.82M
QMMMQMMM Holdings Limited	US$ 1.14 (52.02%)	75.53M
XCURExicure Inc	US$ 27.50 (49.62%)	1.32M
OPIOffice Properties Income Trust	US$ 1.685 (48.46%)	3.66M
SAVACassava Sciences Inc	US$ 4.2201 (-84.06%)	50.19M
CMAXCareMax Inc	US$ 0.4923 (-31.63%)	1.64M
ONCTOncternal Therapeutics Inc	US$ 0.80 (-29.82%)	230.91k
NWTNNWTN Inc	US$ 1.04 (-28.77%)	282.17k
SHOTWSafety Shot Inc	US$ 0.112 (-25.33%)	800
RGTIRigetti Computing Inc	US$ 3.045 (75.00%)	179.82M
ELABElevai Labs Inc	US$ 0.0158 (-21.39%)	140.17M
CTXRCitius Pharmaceuticals Inc	US$ 0.1418 (5.98%)	110.51M
NVDANVIDIA Corporation	US$ 137.60 (-3.06%)	103.39M
SMCISuper Micro Computer Inc	US$ 38.2322 (15.33%)	78.49M

chemist72

chemist72 1分前

gdl

Nov. 25 (UPI) -- President-elect Donald Trump has announced his nominations for his Cabinet, but his proposal for confirming them breaks longstanding norms.

As the Republican-led U.S. Senate voted for a new majority leader -- ultimately selecting Sen. John Thune -- Trump demanded memb

fung_derf

fung_derf 1分前

Well, considering I originally bought this stock on 3/16/21 around $37 and sold for a VERY nice profit, I was VERY happy. The fact I bought back in too soon, I was not as much. The amount I now own is never going to determine my overall happiness, however I do appreciate your concern.
You se

hotdawg

hotdawg 1分前

Good morning Yall

ladykiller50

ladykiller50 1分前

DREAM ON!!!!!!!!!!!!!!!!!!

abh3vt

What is bullish is that the market rally is starting to broaden out and small caps are outperforming the large caps, with money seemingly coming in from the sidelines and some rotation away from big tech. The pessimist would say that this could be late bull stage behavior, but in general small cap

ilovetech

ilovetech 2分前

Red_Right_Hand - You can't teach common sense.

BottomBounce

BottomBounce 2分前

Silver's 44-Year Cup and Handle: The Largest Bullish Formation Ever Seen
https://www.jpost.com/business-and-innovation/precious-metals/article-821271 $SILJ

Jim Beem

Jim Beem 2分前

who would want SEC DELINQUENT ASII .0005s?

NOBODY!

they aren't fools, they're smart by not buying junk shares

SSKILLZ1

SSKILLZ1 2分前

Keep in mind the 500 Index was up about 24% last year and up like 26% this year. That can't continue based on hsitorical averages. It is not just a good year this year. keep in mind the market had outsized returns in 2023 in my opinion.

sluggercjb

sluggercjb 2分前

come on Orca hit the ask ya said you sold last week don't you want to reload while it is cheap ...you may miss out 🙂

dstock07734

dstock07734 2分前

Abstract
Background Glioblastoma (GBM), the most prevalent and aggressive brain cancer, is remarkably resistant to conventional immunotherapies. Single-agent neoadjuvant anti-PD-1 (neo-aPD1) therapy modestly boosts tumor-infiltrating lymphocyte (TIL) activity in GBM patients but fails to conf

glenn1919

glenn1919 2分前

TNYA.....UPLD......UP........MULN.........................https://stockcharts.com/h-sc/ui?s=MULN&p=W&b=5&g=0&id=p84354014936

STILL TOWING

STILL TOWING 2分前

That's a great one..ward wont execute a billion dollar deal until he embezzles another 50k from shareholders..that's priceless..Ward can suck my----..

Curt D

A nice update from the company would be very welcome about right now!

fenixinvest

fenixinvest 3分前

Im going to reach out to them. I see potential but this needs exposure. I see PR's all the time on ihub, they should contact ihub and see how to get it posted here. I was on the bid and just got hit so leetttsss goooooo

FrankMD

FrankMD 3分前

tractor4sale

tractor4sale 4分前

What were your favorite TSOI company highlights for the decade prior to the four years ago? I am sure you must of done some in-depth due diligence into this non profitable otc penny stock before climbing aboard! We already know the Idaho HQ property was considered irrelevant to you!

RCKS

".....bulls have held all the zones I called out last week, so unless something breaks, there's still nothing for bears to write home about yet."

http://www.pretzelcharts.com/

"The market barely moved on Friday, leaving us in the same position, but I've added a new char

timberwolf7

timberwolf7 4分前

How about we start with something 'reasonable' to
begin with??

Like maybe 50 cents if their NDA is accepted for review
Like maybe $3 if they are approved (market cap gets 'inflated' at $3)

and see what sales then justifies...

Or you could h

Mark

$CMAX .51 BK play with under 3m float, good one for the watch list, had "stalking horse" news this morning too.

Hawkeiz

Hawkeiz 5分前

Another step forward as they reinvent this company. Buying here is a good idea

glenn1919

glenn1919 5分前

TNYA...........................https://stockcharts.com/h-sc/ui?s=TNYA&p=W&b=5&g=0&id=p86431144783

Xustreas 3-7 1d

Simple Ledger Protocol Token

SG Issuer Sg Issuer Mc M...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約